Previous studies have confirmed that a single intra-mesencephalic injection of LPS, an activator of microglial TLR4 signaling in the CNS, is sufficient to induce the loss of DA neurons in rodents, mimicking some features of PD pathology [42–45]. This evidence concerns the gene TLR4 and Parkinson disease.